> The Supreme Court has refused to hear a case from Teva Pharmaceuticals looking for a quick approval of a copycat drug for Zoloft. The issue before the court had centered on when federal courts can intervene on proposed generic drug cases. Article
> Celldex has acquired the outstanding shares of Lorantis and all the assets of Alteris Therapeutics. Report
> EntreMed said that a new version of a cancer drug showed anti-tumor activity in preclinical studies. Report
> Allos Therapeutics withdrew its European application for the cancer drug Revaproxyn after a report determined that it did not have sufficient data to warrant approval. The FDA has already decided to wait for data from a new study before considering the drug. Article
> A Merck scientist told a jury that it was "completely outrageous" to suggest that the company had put profits ahead of safety in its handling of Vioxx. Report
And Finally... A new study demonstrates that middle-aged people who exercise are less likely to develop Alzheimer's or dementia. Article